𧬠Ozempic Slowed Biological Aging by Nearly 5 Years in HIV Patients
A 32-week randomized trial published in Nature Communications found that semaglutide β the active ingredient in Ozempic and Wegovy β reduced epigenetic aging by up to 4.9 years in adults with HIV-associated lipohypertrophy. Participants aged more slowly across biological clocks tied to the heart, brain, kidneys, and liver. Scientists caution that larger studies are needed and itβs unclear if the effect extends to people without HIV. Could GLP-1 drugs be the next frontier in anti-aging medicine?
β‘ 48 buzzing
694 views
π 0 subscribed